A carregar...
Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism
ESSENTIALS: There is no data on the use of idarucizumab in children with venous thromboembolism (VTE). We present the design of a trial that will assess the safety of idarucizumab in children with VTE. Patients will be recruited from two ongoing trials in children treated with dabigatran for VTE. Id...
Na minha lista:
| Publicado no: | Res Pract Thromb Haemost |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5868044/ https://ncbi.nlm.nih.gov/pubmed/30046708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12053 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|